Andreas Arendtsen Rostved
Papers
1
Total Citations
6
H-Index
1
About
Andreas Arendtsen Rostved is a dedicated surgical researcher whose work focuses on the oncological management of gastroesophageal junction (GEJ) cancer, with a particular emphasis on peritoneal tumor dissemination. His key research areas include the role of peritoneal washing cytology in staging and the impact of neoadjuvant chemotherapy on tumor cell spread. Rostved’s major contribution lies in systematically evaluating the incidence of free peritoneal tumor cells both before and after neoadjuvant treatment, providing critical insights into how chemotherapy may alter peritoneal involvement in GEJ cancer patients. This work, published in 2019, has garnered 6 citations, reflecting its growing relevance in refining surgical and oncological decision-making. By addressing a previously underexplored aspect of GEJ cancer, Rostved has helped clarify the utility of peritoneal washing as a staging tool, potentially guiding more personalized treatment strategies. His research underscores the importance of integrating cytological assessments into standard protocols, offering a foundation for future studies aimed at improving survival outcomes. Rostved’s meticulous approach and focus on translational impact mark him as a promising contributor to gastrointestinal oncology.
Research Focus
Key Achievements
Top Papers
- 1